tumor tissues; adjacent normal tissue samples; serum
PC9; H460; A549; H1299; BEAS-2B
-
ceRNA regulation (other); PI3K/AKT (other)
Microarray; RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; divergent primers PCR; Clinical Sample Validation; Survival Analysis; ROC Analysis; Bioinformatics Analysis
High levels of circ_0007618 are associated with poor OS in LUAD patients; ROC AUC in tissue 0.916 and in serum 0.838.
circ_0007618 is up-regulated in LUAD tissues, serum, and lung cancer cell lines, is mainly localized in the cytoplasm, and is proposed to act within a predicted ceRNA network by binding multiple miRNAs and regulating hub genes such as PIK3CA and NRAS. High circ_0007618 expression correlates with clinicopathological features and predicts poor overall survival, supporting its potential as a diagnostic/prognostic biomarker.
0.7329
Circular RNA-microRNA-mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma.
combined biological and clinical study